Nina Capitano, - Pharmacist in Scranton, PA

Nina Capitano, is a Pharmacist based in Scranton, Pennsylvania. Nina Capitano is licensed to practice in Pennsylvania (license number RP444970) and her current practice location is 509 Davis St, Scranton, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at (570) 341-3790.

NPI number for Nina Capitano is 1063017440 and her current mailing address is 509 Davis St, Scranton, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1063017440.

Contact Information

Nina Capitano,
509 Davis St,
Scranton, PA 18505-2927
(570) 341-3790
Not Available

Healthcare Provider's Profile

Full NameNina Capitano
GenderFemale
SpecialityPharmacist
Location509 Davis St, Scranton, Pennsylvania
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1063017440
  • Provider Enumeration Date: 12/02/2020
  • Last Update Date: 12/02/2020

Medical Identifiers

Medical identifiers for Nina Capitano such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063017440NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist RP444970 (Pennsylvania)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nina Capitano is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Nina Capitano,
509 Davis St,
Scranton, PA 18505-2927

Ph: () -
Nina Capitano,
509 Davis St,
Scranton, PA 18505-2927

Ph: (570) 341-3790

News Archive

Clinical trial to evaluate maraviroc-based PrEP regimens for HIV prevention

Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection.

New drug target may prevent consequences of ACL tear in athletes

Striking the likes of Chicago Bulls' Derrick Rose, L.A. Lakers' Kobe Bryant and Detroit Tigers' Victor Martinez, tears in the anterior cruciate ligament (ACL) are one of the most rampant and serious knee injuries among athletes.

ImmunoGen reports favorable clinical results from STARLYTE Phase II trial of SAR3419 for DLBCL

ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentation of favorable clinical findings with SAR3419 (coltuximab ravtansine) from the STARLYTE Phase II trial in diffuse large B-cell lymphoma (DLBCL).

Analysis: How your beloved hospital helps to drive up health care costs

As voters fume about the high cost of health care, politicians have been targeting two well-deserved villains: pharmaceutical companies, whose prices have risen more than inflation, and insurers, who pay their executives millions in salaries while raising premiums and deductibles.

State roundup: Another Medi-Cal lawsuit; medical homes in Tenn.; Pa. moving forward on exchanges

Some California hospitals would take a significant and long-lasting hit from Medi-Cal reimbursement cuts recently approved by CMS, according to the California Hospital Association, which this week filed a petition in federal court to put a temporary halt to those reductions. CHA's lawsuit and injunction request are separate from the court action taken earlier this week by the California Medical Association and other provider organizations.

Read more News

› Verified 4 days ago


Pharmacist in Scranton, PA

Dr. Anthony Leonard Possanza, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1800 Mulberry St, Scranton, PA 18510
Phone: 570-703-8090    
Paul Dominick Roczniak, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1011 Scranton Carbondale Hwy, Scranton, PA 18508
Phone: 570-489-4274    Fax: 570-489-1834
Mr. Jason Michael Hapstak, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1011 Scranton Carbondale Hwy, Scranton, PA 18508
Phone: 570-489-4274    Fax: 570-489-1834
Samantha Tucky, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1800 Mulberry St, Scranton, PA 18510
Phone: 570-703-8090    Fax: 570-703-8496
Jeffrey Thomas Bachman, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1777 N Keyser Ave, Scranton, PA 18508
Phone: 570-346-2087    
Kelly Mitchell,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 609 Luzerne St, Scranton, PA 18504
Phone: 570-342-6411    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.